[Effect of OK-432 on activated lysozyme in monocytes and neutrophils --comparison of intravenous and intramuscular administrations].
D001688:Biological Products / Q000494:pharmacology*; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D008175:Lung Neoplasms / Q000201:enzymology / Q000473:pathology; D009000:Monocytes / Q000201:enzymology*; D009113:Muramidase / Q000378:metabolism*; D009504:Neutrophils / Q000201:enzymology*; D010844:Picibanil / Q000008:administration & dosage / Q000494:pharmacology*
D001688:Biological Products; D010844:Picibanil; D009113:Muramidase